Novel Focal Ablation System Proceeds Through Prostate Cancer Pipeline
A streamline procedure allows treatment with the NanoTherm therapy system for focal ablation to be completed within 1 day.
Patient treatment has been completed in the initial part of stage 2 of a pivotal trial of the NanoTherm therapy system for the focal ablation of intermediate-risk prostate cancer, according to MagForce AG, the developer of the therapy.1
source: Josh M. Broderick - Urology Times
Read More About Prostate Cancer
Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter.
ZERO in the News
Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more!
Monthly Newsletter
ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease.
Journey to ZERO
Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events.